Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168431149> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- W3168431149 abstract "Abstract Background and Aims Monotherapy immunotherapy with “check-point inhibitors” (anti PD-1, Anti PD-L1) is an effective therapy to advanced-stage cancer patients. Little is known about our experience and its renal implication, although it is related to fluid and electrolyte disorders or acute kidney failure (AKI). To evaluate changes in natremia or acute renal impairment (primary endpoints) in IV stage cancer patients with lung, bladder or melanoma neoplasm who have received monotherapy with pembrolizumab (PEM), atezolizumab (ATZ) or nivolumab (NIV). At the same time, analyze if there are differences between drug administered, underlying disease or having received cisplatin previously (secondary outcomes). Method single-center retrospective analysis. Inclusion period: January 2015 to September 2020. Dose administered: PEM 2mcg/kg/21 days; ATZ 1200mg/21 days; NIV 3mg/kg/ 21 days. Changes in natremia and GFR (CDK-EPI) were evaluated in 0,1,3 months of follow-up. Patients with combined chemotherapy were excluded. Results 137 patients were included. Mean age: 64 years. Men: 71.6%. Neoplasm: lung (76.8%), bladder (7.2%), melanoma (15.9%). Patients received 27.5% PEM; 26.1% ATZ; 46.4% NIV. Between all of them, 76% had received platinum previously. Up to 13.6% developed hyponatremia and 12.40% AKI 3 months later. The decrease in GFR was significantly greater in bladder neoplasm (mean GFR 42ml / min / m2 p <0.01) at three months. Bladder cancer was also the most frequent (but not significant) in reduced natremia (mean Na 135mEq / L p = 0.08). There were no differences according to drug administration or having received platinum previously. 61% were death, but none of them due to a renal event. Conclusion" @default.
- W3168431149 created "2021-06-22" @default.
- W3168431149 creator A5027073362 @default.
- W3168431149 creator A5037461056 @default.
- W3168431149 creator A5038005579 @default.
- W3168431149 creator A5056017682 @default.
- W3168431149 creator A5061934817 @default.
- W3168431149 creator A5062971484 @default.
- W3168431149 creator A5064158750 @default.
- W3168431149 creator A5076761387 @default.
- W3168431149 creator A5082931762 @default.
- W3168431149 creator A5088678587 @default.
- W3168431149 date "2021-05-01" @default.
- W3168431149 modified "2023-09-23" @default.
- W3168431149 title "MO362CHECK- POINT INHIBITORS AND THEIR KIDNEY INVOLVEMENT" @default.
- W3168431149 doi "https://doi.org/10.1093/ndt/gfab082.0016" @default.
- W3168431149 hasPublicationYear "2021" @default.
- W3168431149 type Work @default.
- W3168431149 sameAs 3168431149 @default.
- W3168431149 citedByCount "0" @default.
- W3168431149 crossrefType "journal-article" @default.
- W3168431149 hasAuthorship W3168431149A5027073362 @default.
- W3168431149 hasAuthorship W3168431149A5037461056 @default.
- W3168431149 hasAuthorship W3168431149A5038005579 @default.
- W3168431149 hasAuthorship W3168431149A5056017682 @default.
- W3168431149 hasAuthorship W3168431149A5061934817 @default.
- W3168431149 hasAuthorship W3168431149A5062971484 @default.
- W3168431149 hasAuthorship W3168431149A5064158750 @default.
- W3168431149 hasAuthorship W3168431149A5076761387 @default.
- W3168431149 hasAuthorship W3168431149A5082931762 @default.
- W3168431149 hasAuthorship W3168431149A5088678587 @default.
- W3168431149 hasConcept C121608353 @default.
- W3168431149 hasConcept C126322002 @default.
- W3168431149 hasConcept C126894567 @default.
- W3168431149 hasConcept C141071460 @default.
- W3168431149 hasConcept C159641895 @default.
- W3168431149 hasConcept C2776256026 @default.
- W3168431149 hasConcept C2776694085 @default.
- W3168431149 hasConcept C2776703092 @default.
- W3168431149 hasConcept C2777472916 @default.
- W3168431149 hasConcept C2777701055 @default.
- W3168431149 hasConcept C2778239845 @default.
- W3168431149 hasConcept C2780030458 @default.
- W3168431149 hasConcept C2780057760 @default.
- W3168431149 hasConcept C2780352672 @default.
- W3168431149 hasConcept C2780472472 @default.
- W3168431149 hasConcept C2781451048 @default.
- W3168431149 hasConcept C71924100 @default.
- W3168431149 hasConcept C90924648 @default.
- W3168431149 hasConceptScore W3168431149C121608353 @default.
- W3168431149 hasConceptScore W3168431149C126322002 @default.
- W3168431149 hasConceptScore W3168431149C126894567 @default.
- W3168431149 hasConceptScore W3168431149C141071460 @default.
- W3168431149 hasConceptScore W3168431149C159641895 @default.
- W3168431149 hasConceptScore W3168431149C2776256026 @default.
- W3168431149 hasConceptScore W3168431149C2776694085 @default.
- W3168431149 hasConceptScore W3168431149C2776703092 @default.
- W3168431149 hasConceptScore W3168431149C2777472916 @default.
- W3168431149 hasConceptScore W3168431149C2777701055 @default.
- W3168431149 hasConceptScore W3168431149C2778239845 @default.
- W3168431149 hasConceptScore W3168431149C2780030458 @default.
- W3168431149 hasConceptScore W3168431149C2780057760 @default.
- W3168431149 hasConceptScore W3168431149C2780352672 @default.
- W3168431149 hasConceptScore W3168431149C2780472472 @default.
- W3168431149 hasConceptScore W3168431149C2781451048 @default.
- W3168431149 hasConceptScore W3168431149C71924100 @default.
- W3168431149 hasConceptScore W3168431149C90924648 @default.
- W3168431149 hasLocation W31684311491 @default.
- W3168431149 hasOpenAccess W3168431149 @default.
- W3168431149 hasPrimaryLocation W31684311491 @default.
- W3168431149 hasRelatedWork W16009006 @default.
- W3168431149 hasRelatedWork W16144067 @default.
- W3168431149 hasRelatedWork W17091652 @default.
- W3168431149 hasRelatedWork W20207445 @default.
- W3168431149 hasRelatedWork W20926677 @default.
- W3168431149 hasRelatedWork W4846259 @default.
- W3168431149 hasRelatedWork W5372512 @default.
- W3168431149 hasRelatedWork W6347959 @default.
- W3168431149 hasRelatedWork W8240937 @default.
- W3168431149 hasRelatedWork W893482 @default.
- W3168431149 isParatext "false" @default.
- W3168431149 isRetracted "false" @default.
- W3168431149 magId "3168431149" @default.
- W3168431149 workType "article" @default.